Legal Opinion
Gilliland v. Novartis Pharmaceuticals Corp.
District Court, S.D. Iowa
Decided July 28, 2014No. 1:12-cv-00029Published
1Opinion of the Court
ORDER
ROBERT W. PRATT, District Judge.
Before the Court is Novartis Pharmaceuticals Corporation’s (“Novartis”) Motion To Find That Punitive Damages Are Unavailable (“Motion”),1 filed May 15, 2014. Clerk’s No. 82. On June 17, 2014, Denise Gilliland (“Gilliland”) filed a response. Clerk’s No. 94. Novartis replied on July 1, 2014. Clerk’s No. 103. The Motion is fully submitted.2
I. FACTUAL AND PROCEDURAL BACKGROUND3
On June 17, 2005, Gilliland was diagnosed with multiple myeloma. As a part of her treatment regimen, she received Zometa infusions from July 1, 2005 until May 1, 2009 when she…
2Cases cited25 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Parklane Hosiery Co. v. ShoreSupreme Court of the United States · 1979
- Poller v. Columbia Broadcasting System, Inc.Supreme Court of the United States · 1962
- Sandra L. Waldridge v. American Hoechst Corp.Court of Appeals for the Seventh Circuit · 1994
20 more not listed; retrieve them via the Exa API.